Sale disclosed
Jim Wassil
EVP, Chief Scientific Ofc, COO
Common Stock
- Reported value
- $1.56M
- Reported price
- $86.74 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Vaxcyte, Inc.
Last 30 daysNo qualifying insider buying. Sales: $3.5M by 2 insiders.
Showing the first 6 of 20 trades on this page.
EVP, Chief Scientific Ofc, COO
Common Stock
SVP, Finance & CAO
Common Stock
EVP, Chief Scientific Ofc, COO
Common Stock
EVP, Chief Scientific Ofc, COO
Common Stock
EVP, Chief Scientific Ofc, COO
Common Stock
EVP, Chief Scientific Ofc, COO
Common Stock
CHIEF OPERATING OFFICER
Common Stock
CHIEF OPERATING OFFICER
Common Stock
CHIEF OPERATING OFFICER
Common Stock
CHIEF OPERATING OFFICER
Common Stock
Chief Technical Ops Officer
Common Stock
CHIEF OPERATING OFFICER
Common Stock
CHIEF OPERATING OFFICER
Common Stock
PRESIDENT AND CFO
Common Stock
PRESIDENT AND CFO
Common Stock
CHIEF EXECUTIVE OFFICER
Common Stock
CHIEF EXECUTIVE OFFICER
Common Stock
CHIEF EXECUTIVE OFFICER
Common Stock
CHIEF EXECUTIVE OFFICER
Common Stock
CHIEF EXECUTIVE OFFICER
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| EVP, Chief Scientific Ofc, COO | Common StockSale10b5-1 | 18,000$86.74 / share | $1.56M | Oct 5Filed Oct 7 · 2d later | SEC filing |
| SVP, Finance & CAO | Common StockSale10b5-1 | 19,000$86.74 / share | $1.65M | Oct 5Filed Oct 7 · 2d later | SEC filing |
| EVP, Chief Scientific Ofc, COO | Common StockSale10b5-12 trades | 2,250avg $56.67 / share | $127.51K | Oct 1Filed Oct 2 · 1d later | 2 filings
|
| EVP, Chief Scientific Ofc, COO | Common StockSale10b5-1 | 1,381$61.16 / share | $84.46K | Sep 4Filed Sep 9 · 5d later | SEC filing |
| EVP, Chief Scientific Ofc, COO | Common StockSale10b5-1 | 1,334$59.52 / share | $79.4K | Sep 9Filed Sep 9 · 0d later | SEC filing |
| CHIEF OPERATING OFFICER | Common StockSale10b5-14 trades | 3,477avg $61.07 / share | $212.35K | Sep 1Filed Sep 2 · 1d later | 4 filings
|
| Chief Technical Ops Officer | Common StockSale10b5-1 | 17,000$55.00 / share | $935.07K | Aug 5Filed Aug 5 · 0d later | SEC filing |
| CHIEF OPERATING OFFICER | Common StockSale10b5-12 trades | 2,250avg $53.86 / share | $121.19K | Aug 3Filed Aug 5 · 2d later | 2 filings
|
| PRESIDENT AND CFO | Common StockSale10b5-12 trades | 10,000avg $53.89 / share | $538.88K | Aug 3Filed Aug 5 · 2d later | 2 filings
|
| CHIEF EXECUTIVE OFFICER | Common StockSale10b5-15 trades | 17,820avg $55.63 / share | $991.24K | Jul 27Filed Jul 28 · 1d later | 5 filings
|
Showing the latest 20 of 46 trades. Show all 46 trades
Vaxcyte, Inc. - Common Stock (PCVX) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberVaxcyte, Inc. - Common Stock (PCVX) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberVaxcyte, Inc. - Common Stock (PCVX) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.